| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/03/2013 | US20130004490 Delivery of transthyretin across the blood-brain barrier as a treatment for alzheimer's disease |
| 01/03/2013 | US20130004471 Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy |
| 01/03/2013 | US20130004467 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
| 01/03/2013 | US20130004466 Myogenic differentiation of stem cells and and uses thereof |
| 01/03/2013 | US20130004461 Subfamily e simian adenoviruses a1321, a1325, a1295, a1309, a1316 and a1322 and uses thereof |
| 01/03/2013 | US20130004416 Dual Variable Domain Immunoglobulin and Uses Thereof |
| 01/03/2013 | DE102011118019A1 Varianten des Promotors des für die Glyzerinaldehyd-3-phosphat-Dehydrogenase kodierenden gap-Gens Variants of the promoter of the gene encoding the glyceraldehyde-3-phosphate dehydrogenase gene GAP |
| 01/03/2013 | DE10114189B4 Verfahren zur Gewinnung von Wertstoffen aus Organismen durch Beeinflussung/Beeinträchtigung der zelleigenen Transportsysteme für diese Wertstoffe bzw. durch Verwendung von Produktionsstämmen, denen besagte Transportsysteme fehlen Process for the recovery of valuable materials from organisms by affecting / impairment of cell-specific transport systems for these valuable materials or by the use of production strains, which said transport systems are missing |
| 01/03/2013 | CA2841158A1 Microrna-31 compositions and methods for use in autoimmune disease |
| 01/03/2013 | CA2840630A1 Alfalfa plant and seed corresponding to transgenic event kk 179-2 and methods for detection thereof |
| 01/03/2013 | CA2840614A1 Methods for modulating kallikrein (klkb1) expression |
| 01/03/2013 | CA2840542A1 Methods and compositions for enrichment of nucleic acids in mixtures of highly homologous sequences |
| 01/03/2013 | CA2840528A1 Methods and compositions for segregating target nucleic acid from mixed nucleic acid samples |
| 01/03/2013 | CA2840525A1 Modified plants with increased oil content |
| 01/03/2013 | CA2840493A1 Method for genome complexity reduction and polymorphism detection |
| 01/03/2013 | CA2840143A1 Composition comprising inhibitors of irs-1 and of vegf |
| 01/03/2013 | CA2839938A1 Photoactivatable receptors and their uses |
| 01/03/2013 | CA2839668A1 Epitope and its use of hepatitis b virus surface antigen |
| 01/03/2013 | CA2839663A1 Receptor gene for peptide cancer antigen-specific t cell |
| 01/03/2013 | CA2839633A1 Peptides with viral infection enhancing properties and their use |
| 01/03/2013 | CA2839539A1 Heterodimerized polypeptide |
| 01/03/2013 | CA2839506A1 Canine coronavirus vaccine |
| 01/03/2013 | CA2838795A1 Phacosporacea resistant soybean plants |
| 01/03/2013 | CA2833778A1 Compositions and methods for inhibiting gene expression of hepatitis b virus |
| 01/02/2013 | EP2540839A1 Method for determining presence or absence of cancer cell in biological sample, and molecular marker and kit for determination |
| 01/02/2013 | EP2540838A1 Kit for quantitative detection of braf mutation |
| 01/02/2013 | EP2540836A1 Process for production of cadaverine |
| 01/02/2013 | EP2540835A1 PROCESS FOR PRODUCTION OF POLYHYDROXYALKANOIC ACID USING GENETICALLY MODIFIED MICROORGANISM HAVING ENOYL-CoA HYDRATASE GENE INTRODUCED THEREIN |
| 01/02/2013 | EP2540832A1 Plants transformed with a small inducible kinase having improved yield related traits and a method for making the same |
| 01/02/2013 | EP2540831A2 Transgenic plants with enhanced agronomic traits |
| 01/02/2013 | EP2540830A2 Tobacco plants having reduced nicotine demethylase activity |
| 01/02/2013 | EP2540829A1 Marker for detection of myogenic diseases, and method for detection of the diseases using same |
| 01/02/2013 | EP2540828A1 Composition comprising inhibitors of IRS-1 and of VEGF |
| 01/02/2013 | EP2540827A1 Anti-icam3 antibody and use thereof |
| 01/02/2013 | EP2540826A1 Method for producing glucuronic acid conjugate using saccharomyces cerevisiae |
| 01/02/2013 | EP2540823A1 Novel restriction endonucleases, DNA encoding these endonucleases and methods for identifying new endonucleases with the same or varied specificity |
| 01/02/2013 | EP2540822A1 Method for identification of oncogene, method for establishment of cell capable of expressing oncogene, and method for screening for oncogene-targeting substance |
| 01/02/2013 | EP2540817A1 Methods and recombinant microbial hosts for the production of isobutanol |
| 01/02/2013 | EP2540816A1 Method for constructing novel bacterium belonging to the genus bifidobacterium |
| 01/02/2013 | EP2540745A1 Fully humanized anti-her2 antibody, preparation method and use thereof |
| 01/02/2013 | EP2540744A1 Fully human monoclonal antibody to vegf, preparation method and use thereof |
| 01/02/2013 | EP2540740A2 Multimeric TNF receptors |
| 01/02/2013 | EP2540389A1 Method of encapsulating a molecule and a microbead |
| 01/02/2013 | EP2540314A1 Raccoon poxvirus expressing rabies glycoproteins |
| 01/02/2013 | EP2540302A1 Methods and pharmaceutical compositions for healing wounds |
| 01/02/2013 | EP2540301A2 Methods and pharmaceutical compositions for healing wounds |
| 01/02/2013 | EP2539472A2 Fast pcr for str genotyping |
| 01/02/2013 | EP2539465A2 Analyte sequencing with nanopores |
| 01/02/2013 | EP2539464A2 Amplification methods to minimise sequence specific bias |
| 01/02/2013 | EP2539456A1 Increasing plant growth by modulating omega-amidase expression in plants |
| 01/02/2013 | EP2539455A2 Complexes of an3-interacting proteins and their use for plant growth promotion |
| 01/02/2013 | EP2539454A1 Plants having enhanced yield-related traits and a method for making the same |
| 01/02/2013 | EP2539453A2 Plants having enhanced yield-related traits and a method for making the same |
| 01/02/2013 | EP2539452A2 Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1 |
| 01/02/2013 | EP2539451A1 Compositions for targeted delivery of sirna |
| 01/02/2013 | EP2539450A2 Method of making nucleic acid libraries |
| 01/02/2013 | EP2539449A1 Process for parallel isolation and/or purification of rna and dna |
| 01/02/2013 | EP2539440A2 Derivation of hematopoietic cells from adult mesenchymal stem cells |
| 01/02/2013 | EP2539430A1 Method for increasing n-glycosylation site occupancy on therapeutic glycoproteins produced in pichia pastoris |
| 01/02/2013 | EP2539369A1 Antagonist anti-il-7 receptor antibodies and methods |
| 01/02/2013 | EP2539365A2 Method of inducing the production of protective anti-hiv-1 antibodies |
| 01/02/2013 | EP2539362A1 Nematode-resistant transgenic plants |
| 01/02/2013 | EP2539361A1 Plants having enhanced yield-related traits and a method for making the same |
| 01/02/2013 | EP2539357A2 Methods and compositions for the detection and treatment of cancer involving mirnas and mirna inhibitors and targets |
| 01/02/2013 | EP2539356A1 Modulation of smad3 expression |
| 01/02/2013 | EP2538972A1 Recombinant cdv compositions and uses thereof |
| 01/02/2013 | EP2538964A1 Modulation of cytokine-induced chronic inflammatory responses |
| 01/02/2013 | EP1598422B1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants |
| 01/02/2013 | CN1886148B Selective inhibition of NF-kB activation by peptides designed to disrupt NEMO oligomerization |
| 01/02/2013 | CN1854157B Antibodies to insulin-like growth factor i receptor |
| 01/02/2013 | CN1723285B Recombinant MVA and method for generation thereof |
| 01/02/2013 | CN1720331B Method for obtaining a bifunctional complex |
| 01/02/2013 | CN1671416B Super humanized antibodies |
| 01/02/2013 | CN1658899B Modified CEA nucleic acid and expression vectors |
| 01/02/2013 | CN1454215B Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/02/2013 | CN102859002A PCR test method which eliminates false-negatives, and primer used in the same |
| 01/02/2013 | CN102858998A Novel genomic biomarkers for irritable bowel syndrome diagnosis |
| 01/02/2013 | CN102858985A Method for genome editing |
| 01/02/2013 | CN102858984A Plants having enhanced yield-related traits and a method for making the same |
| 01/02/2013 | CN102858983A Compositions And Methods For Minimizing Nornicotine Synthesis In Tobacco |
| 01/02/2013 | CN102858982A A method for increasing photosynthetic carbon fixation using glycolate dehydrogenase multi-subunit fusion protein |
| 01/02/2013 | CN102858981A High level expression of recombinant CRM197 |
| 01/02/2013 | CN102858980A Homologous recombination in an algal nuclear genome |
| 01/02/2013 | CN102858979A Treatment Of Fibroblast Growth Factor 21 (FGF21) Related Diseases By Inhibition Of Natural Antisense Transcript To FGF21 |
| 01/02/2013 | CN102858978A High-purity soluble thrombomodulin and method for producing same |
| 01/02/2013 | CN102858977A Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858976A Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858975A Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858974A Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858973A Method for preparing arna and method for assaying gene expression |
| 01/02/2013 | CN102858970A Compositions and methods comprising variant proteases |
| 01/02/2013 | CN102858969A Novel ss-glucosidase and uses thereof |
| 01/02/2013 | CN102858966A Improved meganuclease recombination system |
| 01/02/2013 | CN102858963A Anti-trypanosomiasis vaccines and diagnostics |
| 01/02/2013 | CN102858960A Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages |
| 01/02/2013 | CN102858959A Oncolytic rhabdovirus |
| 01/02/2013 | CN102858958A Induced Hepatic Stem Cell And Process For Production Thereof, And Applications Of The Cell |
| 01/02/2013 | CN102858949A Method for increasing n-glycosylation site occupancy on therapeutic glycoproteins produced in pichia pastoris |
| 01/02/2013 | CN102858799A Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858796A Oligomer-specific amyloid beta epitope and antibodies |